Header Logo

Connection

Andrew Karter to Hypoglycemic Agents

This is a "connection" page, showing publications Andrew Karter has written about Hypoglycemic Agents.
Connection Strength

5.751
  1. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
    View in: PubMed
    Score: 0.515
  2. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017 10 01; 177(10):1461-1470.
    View in: PubMed
    Score: 0.489
  3. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2018 04; 53(2):1227-1247.
    View in: PubMed
    Score: 0.475
  4. Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus. J Am Geriatr Soc. 2017 01; 65(1):77-82.
    View in: PubMed
    Score: 0.455
  5. Financial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2016 Apr; 51(2):610-24.
    View in: PubMed
    Score: 0.421
  6. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2015 Apr; 50(2):537-59.
    View in: PubMed
    Score: 0.393
  7. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010 Jan; 16(1):33-40.
    View in: PubMed
    Score: 0.286
  8. Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007 Nov; 13(11):598-606.
    View in: PubMed
    Score: 0.246
  9. Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med. 2005 Aug; 22(8):986-93.
    View in: PubMed
    Score: 0.210
  10. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes. JAMA. 2021 06 08; 325(22):2273-2284.
    View in: PubMed
    Score: 0.158
  11. Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes. Diabetes Care. 2021 03; 44(3):e40-e41.
    View in: PubMed
    Score: 0.154
  12. Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
    View in: PubMed
    Score: 0.142
  13. Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. BMC Health Serv Res. 2019 Jun 25; 19(1):422.
    View in: PubMed
    Score: 0.138
  14. Surveillance of Hypoglycemia-Limitations of Emergency Department and Hospital Utilization Data. JAMA Intern Med. 2018 07 01; 178(7):987-988.
    View in: PubMed
    Score: 0.129
  15. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370. Diabetes Care. 2017 02; 40(2):e26.
    View in: PubMed
    Score: 0.117
  16. Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study. J Manag Care Spec Pharm. 2015 Aug; 21(8):688-98.
    View in: PubMed
    Score: 0.105
  17. An algorithm to identify medication nonpersistence using electronic pharmacy databases. J Am Med Inform Assoc. 2015 Sep; 22(5):957-61.
    View in: PubMed
    Score: 0.104
  18. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
    View in: PubMed
    Score: 0.103
  19. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.102
  20. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug; 54(4):374-82.
    View in: PubMed
    Score: 0.097
  21. Safety and effectiveness of mail order pharmacy use in diabetes. Am J Manag Care. 2013 Nov; 19(11):882-7.
    View in: PubMed
    Score: 0.093
  22. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educ. 2012 Jan-Feb; 38(1):94-100.
    View in: PubMed
    Score: 0.082
  23. Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study. J Gen Intern Med. 2011 May; 26(5):505-11.
    View in: PubMed
    Score: 0.076
  24. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf. 2010 Jul; 19(7):715-21.
    View in: PubMed
    Score: 0.074
  25. Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med. 2010 Sep; 25(9):962-8.
    View in: PubMed
    Score: 0.073
  26. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010 Apr; 33(4):733-5.
    View in: PubMed
    Score: 0.072
  27. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med. 2009 Nov; 71(9):965-72.
    View in: PubMed
    Score: 0.070
  28. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care. 2009 Jun; 32(6):971-6.
    View in: PubMed
    Score: 0.067
  29. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care. 2008 Feb; 31(2):261-6.
    View in: PubMed
    Score: 0.062
  30. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med. 2005 Sep; 118(Suppl 9A):20S-26S.
    View in: PubMed
    Score: 0.053
  31. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004 Feb; 42(2):110-5.
    View in: PubMed
    Score: 0.047
  32. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec 01; 20(12):e573-81.
    View in: PubMed
    Score: 0.025
  33. Update on health literacy and diabetes. Diabetes Educ. 2014 Sep-Oct; 40(5):581-604.
    View in: PubMed
    Score: 0.024
  34. Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health (Larchmt). 2013 Dec; 22(12):1049-55.
    View in: PubMed
    Score: 0.023
  35. Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Intern Med. 2013 Feb 11; 173(3):210-8.
    View in: PubMed
    Score: 0.022
  36. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.
    View in: PubMed
    Score: 0.019
  37. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
    View in: PubMed
    Score: 0.017
  38. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
    View in: PubMed
    Score: 0.016

© 2024 Kaiser Permanente